Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for February 2015. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
AMA: Key Steps for Minimizing Liability Risk in Telemedicine
FRIDAY, Feb. 27, 2015 (HealthDay News) — Key steps should be taken to minimize the potential risk of liability resulting from use of telemedicine, according to an article published by the American Medical Association (AMA).
Patients Say Cost Matters Greatly in Choosing Doctor
FRIDAY, Feb. 20, 2015 (HealthDay News) — The number one determining factor for selecting a doctor is whether the physician is in-network, according to a report published by Vitals.
Measles Can Lead to Ophthalmic Complications
FRIDAY, Feb. 20, 2015 (HealthDay News) — In the midst of the current resurgence of measles across the United States, ophthalmologists are warning that even before the telltale skin rash appears, the infection typically shows up in the eyes. In rare cases, measles can trigger long-term vision problems and even blindness.
Doctors, Pharmacists Least Likely Health Pros to Divorce
THURSDAY, Feb. 19, 2015 (HealthDay News) — Doctors appear less likely to get divorced than most other health care professionals, according to research published online Feb. 18 in The BMJ.
Full Text
Editorial subscription or payment may be required)
Fear of Discrimination Keeps Many LGBT Med Students Silent
THURSDAY, Feb. 19, 2015 (HealthDay News) — Fear of discrimination is a major reason why about one-third of lesbian, gay, bisexual, and transgender (LGBT) medical students stay “in the closet,” new research finds. The study was published online Feb. 16 in Academic Medicine.
Full Text (subscription or payment may be required)
Three Meds for Diabetic Macular Edema Compared
THURSDAY, Feb. 19, 2015 (HealthDay News) — New research compared three leading drugs for diabetic macular edema — bevacizumab (Avastin), aflibercept (Eylea), and ranibizumab (Lucentis) — and although aflibercept came out on top, all were effective options. The study was published online Feb. 18 in the New England Journal of Medicine.
Article Emphasizes Importance of Apology in Medical Error
WEDNESDAY, Feb. 18, 2015 (HealthDay News) — Apology laws, which prohibit certain statements or expressions of sympathy by a physician from being admissible in a lawsuit, are unnecessary if physicians understand the importance of saying sorry and offering accountability after an error, according to an article published Feb. 4 in Medical Economics.
Full Text
More Visual Symptoms for Stereoscopic 3D Movie Viewers
TUESDAY, Feb. 17, 2015 (HealthDay News) — Spectators of stereoscopic three-dimensional (S3D) movies report a higher level of external than internal symptoms, and more visual symptoms than 2D movie spectators, according to a study published online Feb. 13 in Ophthalmic & Physiological Optics.
High Deductible Plans Factor Into Physician-Patient Relationship
MONDAY, Feb. 16, 2015 (HealthDay News) — In an environment where patients are increasingly aware of the costs of health care, physicians need to be prepared to address these issues with their patients, according to an article published Feb. 4 in Medical Economics.
Full Text
Patients Tend to Prefer Formal Physician Attire
FRIDAY, Feb. 13, 2015 (HealthDay News) — Patients often prefer physicians with formal attire and white coats, according to a systematic review published online Jan. 19 in BMJ Open.
Latino Physician Shortage Has Worsened Since 1980
FRIDAY, Feb. 13, 2015 (HealthDay News) — From 1980 to 2010 the Latino physician shortage worsened, according to a study published online Jan. 27 in Academic Medicine.
Full Text (subscription or payment may be required)
Seven Tips Help Doctors Prepare for Meaningful Use Audits
WEDNESDAY, Feb. 11, 2015 (HealthDay News) — Given that physicians are chosen for meaningful use (MU) audits at random, the best way to prepare is for a physician to assume they will be audited, according to an article published Jan. 28 in Medical Economics.
Research Misconduct ID’d by FDA Often Unreported in Literature
TUESDAY, Feb. 10, 2015 (HealthDay News) — A review of U.S. Food and Drug Administration inspection reports between 1998 and 2013 revealed 57 clinical trials in which regulators had uncovered violations serious enough to earn the agency’s most severe classification — “official action indicated,” or OAI. The findings were published online Feb. 9 in JAMA Internal Medicine.
Confidence Not Accurate Measure of Prescribing Competence
MONDAY, Feb. 9, 2015 (HealthDay News) — For medical students, self-reported confidence in prescribing only weakly correlates with actual competence, according to a study published online Feb. 4 in The Journal of Clinical Pharmacology.
FDA Expands Approval of Lucentis for Diabetic Retinopathy
MONDAY, Feb. 9, 2015 (HealthDay News) — The U.S. Food and Drug Administration has expanded the approved use for Lucentis (ranibizumab injection) 0.3 mg to treat diabetic retinopathy in patients with diabetic macular edema.
Motivational Interviewing Can Help Reach Nonadherent Patients
FRIDAY, Feb. 6, 2015 (HealthDay News) — Motivational interviewing can be a useful approach for reaching noncompliant patients, according to an article published Jan. 22 in Medical Economics.
Perspective on Dr. Davidson: ‘Be Like Mike’
THURSDAY, Feb. 5, 2015 (HealthDay News) — The tragic shooting of surgeon Michael Davidson can be used as an opportunity to find meaning in tragedy, according to a perspective piece published online Feb. 5 in the New England Journal of Medicine.
Full Text
Patient Engagement Can Cut Costs, Improve Outcomes
MONDAY, Feb. 2, 2015 (HealthDay News) — Patient engagement initiatives can decrease costs without sacrificing quality care, according to an article published Jan. 22 in Medical Economics.
Copyright © 2015 ScoutNews, LLC. All rights reserved.
